Skip to main content
logo
Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
188.97
-1.23 (-0.65%)
At close: Dec 31, 2025, 4:00 PM EST
189.07
+0.10 (0.05%)
After-hours: Dec 31, 2025, 5:25 PM EST

Ligand Pharmaceuticals Revenue

Ligand Pharmaceuticals had revenue of $115.46M in the quarter ending September 30, 2025, with 122.85% growth. This brings the company's revenue in the last twelve months to $251.23M, up 64.83% year-over-year. In the year 2024, Ligand Pharmaceuticals had annual revenue of $167.13M with 27.28% growth.

Revenue (ttm)
$251.23M
Revenue Growth
+64.83%
P/S Ratio
14.50
Revenue / Employee
$3,694,603
Employees
68
Market Cap
3.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024167.13M35.82M27.28%
Dec 31, 2023131.31M-64.93M-33.09%
Dec 31, 2022196.25M-45.30M-18.75%
Dec 31, 2021241.54M77.98M47.68%
Dec 31, 2020163.56M43.28M35.98%
Dec 31, 2019120.28M-131.17M-52.17%
Dec 31, 2018251.45M110.35M78.21%
Dec 31, 2017141.10M32.13M29.48%
Dec 31, 2016108.97M37.06M51.53%
Dec 31, 201571.91M7.38M11.43%
Dec 31, 201464.54M15.57M31.78%
Dec 31, 201348.97M17.59M56.02%
Dec 31, 201231.39M1.35M4.50%
Dec 31, 201130.04M6.50M27.61%
Dec 31, 201023.54M-15.40M-39.55%
Dec 31, 200938.94M11.63M42.56%
Dec 31, 200827.32M14.42M111.84%
Dec 31, 200712.89M8.92M224.21%
Dec 31, 20063.98M-6.24M-61.07%
Dec 31, 200510.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

LGND News

More News